Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;70(3):342-5.
doi: 10.1111/j.1365-2125.2009.03569.x.

Drugs, money and society (Part II)

Tom Walley  1
Affiliations

Drugs, money and society (Part II)

Tom Walley. Br J Clin Pharmacol. 2010 Sep.

Abstract

Pharmacoeconomics started as marketing but has developed into a valuable tool in the fuller assessment of drug therapies. Its principles are now widely accepted, and many countries have government-funded agencies with responsibility for its application, most notably the National Institute for Health and Clinical Excellence in England. Many clinical pharmacologists are active in this area, and the discipline itself is part of the clinical pharmacology trainees' curriculum. Further developments will include value-based pricing and its use in cost sharing arrangements between health service and manufacturers.

PubMed Disclaimer

References

    1. Hiatt HH. Protecting the medical commons: who is responsible? N Engl J Med. 1975;293:235–41. - PubMed
    1. Cochrane AL. Effectiveness and Efficiency: Random Reflections on Health Services. London: Royal Society of Medicine; 1999.
    1. Hillman AL, Eisenberg JM, Pauly MV, Bloom BS, Glick H, Kinosian B, Schwartz JS. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N Engl J Med. 1991;324:1362–5. - PubMed
    1. Kassirer JP, Angell M. The journal's policy on cost-effectiveness analyses. N Engl J Med. 1994;331:669–70. - PubMed
    1. Sacristán JA, Bolaños E, Hernández JM, Soto J, Galende I. Publication bias in health economic studies. Pharmacoeconomics. 1997;11:289–92. - PubMed